Mr. Speaker, the federal government is responsible for the Canada Health Act, which speaks clearly to the issue of accessibility, of universality. Accessibility means regardless of ability to pay; and accessibility means it does not really matter where one lives. So the federal government has a role to play to ensure that the federal government looks at the manufacturing standards and the safety of the manufacturing of drugs in the country. If the federal government had done that, it would not have okayed Sandoz just before the FDA sent it the last letter. It would have also known there was a problem with it.
The other thing that the minister might want to know—